Cancer drug resistance: old concept, novel solutions required.
作者信息
Peeper Daniel S
机构信息
Netherlands Cancer Institute, Division of Molecular Oncology, Amsterdam, The Netherlands.
出版信息
Mol Oncol. 2014 Sep 12;8(6):1064-6. doi: 10.1016/j.molonc.2014.07.026. Epub 2014 Aug 7.
Abstract
摘要
相似文献
1
Cancer drug resistance: old concept, novel solutions required.癌症耐药性：旧概念，需要新解决方案。
Mol Oncol. 2014 Sep 12;8(6):1064-6. doi: 10.1016/j.molonc.2014.07.026. Epub 2014 Aug 7.
2
Drug-based cancer therapy to overcome immune resistance by steering tumor evolution.通过引导肿瘤进化来克服免疫抗性的基于药物的癌症治疗。
Expert Opin Drug Discov. 2019 Jan;14(1):5-8. doi: 10.1080/17460441.2019.1550066. Epub 2018 Nov 29.
3
Overcoming multidrug resistance in cancer: 35 years after the discovery of ABCB1.攻克癌症中的多药耐药性：ABCB1发现35年后
Drug Resist Updat. 2012 Feb-Apr;15(1-2):2-4. doi: 10.1016/j.drup.2012.03.001. Epub 2012 Mar 31.
4
LncRNA regulation: New frontiers in epigenetic solutions to drug chemoresistance.长链非编码 RNA 调控：药物化疗耐药性的表观遗传解决方案的新前沿。
Biochem Pharmacol. 2021 Jul;189:114228. doi: 10.1016/j.bcp.2020.114228. Epub 2020 Sep 23.
5
Correlation of anti-tumour drug resistance with epigenetic regulation.抗肿瘤药物耐药性与表观遗传调控的相关性。
Br J Cancer. 2021 Feb;124(4):681-682. doi: 10.1038/s41416-020-01183-y. Epub 2020 Dec 3.
6
New Strategies to Overcome Resistance to Chemotherapy and Immune System in Cancer.克服癌症化疗和免疫系统耐药性的新策略。
Int J Mol Sci. 2019 Sep 26;20(19):4783. doi: 10.3390/ijms20194783.
7
Biomarkers of Bad Biology: Curse or a Blessing?不良生物学的生物标志物：祸还是福？
Ann Surg Oncol. 2019 Feb;26(2):318-320. doi: 10.1245/s10434-018-07105-w. Epub 2018 Dec 11.
8
Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance.奥沙利铂耐药的肿瘤相关分子机制
Mol Cancer Ther. 2015 Aug;14(8):1767-76. doi: 10.1158/1535-7163.MCT-14-0636. Epub 2015 Jul 16.
9
An old paradigm for treating cancer and other diseases in the 21st century.21世纪治疗癌症和其他疾病的一种旧模式。
Cancer Metastasis Rev. 1998 Jun;17(2):149-54. doi: 10.1023/a:1006058200588.
10
Genetic and epigenetic factors in anticancer drug resistance.抗癌药物耐药性中的遗传和表观遗传因素。
J Natl Cancer Inst. 2000 Jan 5;92(1):4-5. doi: 10.1093/jnci/92.1.4.
引用本文的文献
1
Functions of non-coding RNAs in regulating cancer drug targets.非编码 RNA 在调控癌症药物靶点中的功能。
Acta Biochim Biophys Sin (Shanghai). 2022 Mar 25;54(3):279-291. doi: 10.3724/abbs.2022006.
2
Epimedokoreanin C, a prenylated flavonoid isolated from , induces non-apoptotic cell death with the characteristics of methuosis in lung cancer cells.淫羊藿朝鲜淫羊藿苷C，一种从[来源未提及]中分离出的异戊烯基黄酮，可诱导肺癌细胞发生具有自噬样特征的非凋亡性细胞死亡。
Am J Cancer Res. 2021 Jul 15;11(7):3496-3514. eCollection 2021.
3
Organotypic Models in Drug Development "Tumor Models and Cancer Systems Biology for the Investigation of Anticancer Drugs and Resistance Development".药物开发中的器官型模型：“用于抗癌药物和耐药性研究的肿瘤模型和癌症系统生物学”。
Handb Exp Pharmacol. 2021;265:269-301. doi: 10.1007/164_2020_369.
本文引用的文献
1
No longer an untreatable disease: how targeted and immunotherapies have changed the management of melanoma patients.不再是无法治疗的疾病：靶向治疗和免疫治疗如何改变黑色素瘤患者的治疗管理
Mol Oncol. 2014 Sep 12;8(6):1140-58. doi: 10.1016/j.molonc.2014.07.027. Epub 2014 Aug 15.
2
Acquired and intrinsic resistance in cancer immunotherapy.癌症免疫治疗中的获得性耐药和内在性耐药。
Mol Oncol. 2014 Sep 12;8(6):1132-9. doi: 10.1016/j.molonc.2014.07.011. Epub 2014 Jul 24.
3
Tumour heterogeneity and the evolution of polyclonal drug resistance.肿瘤异质性与多克隆耐药性的演变
Mol Oncol. 2014 Sep 12;8(6):1095-111. doi: 10.1016/j.molonc.2014.06.005. Epub 2014 Jul 10.
4
Reading between the lines; understanding drug response in the post genomic era.字里行间解读：后基因组时代的药物反应理解
Mol Oncol. 2014 Sep 12;8(6):1112-9. doi: 10.1016/j.molonc.2014.05.014. Epub 2014 Jun 10.
5
Brain metastasis: new opportunities to tackle therapeutic resistance.脑转移：应对治疗耐药性的新机遇。
Mol Oncol. 2014 Sep 12;8(6):1120-31. doi: 10.1016/j.molonc.2014.05.009. Epub 2014 Jun 2.
6
Acquired resistance to EGFR-targeted therapies in colorectal cancer.结直肠癌中对表皮生长因子受体（EGFR）靶向治疗的获得性耐药
Mol Oncol. 2014 Sep 12;8(6):1084-94. doi: 10.1016/j.molonc.2014.05.003. Epub 2014 May 14.
7
Drug resistance to targeted therapies: déjà vu all over again.对靶向治疗的耐药性：似曾相识的感觉再次出现。
Mol Oncol. 2014 Sep 12;8(6):1067-83. doi: 10.1016/j.molonc.2014.05.004. Epub 2014 May 21.
8
Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what?癌症药物多药耐药性：泵、癌症干细胞、静止、上皮间质转化、阻断细胞死亡途径、持久细胞或其他？
Open Biol. 2012 May;2(5):120066. doi: 10.1098/rsob.120066.
Zotero 插件